Back

CME Outfitters, LLC

  • HIV Infections
  • Injections

Expanding Access Optimizing Use of Long-Acting Injectable PrEP

Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) represents a major advancement in HIV prevention, offering new opportunities to support adherence and reduce transmission, yet its optimal use remains underrealized across global healthcare settings. Many HIV/infectious disease specialists, primary care clinicians, and pharmacists worldwide lack clarity on patient selection criteria, initiation and transition strategies, and long-term monitoring requirements for LAI PrEP. These gaps, coupled with limited training and implementation barriers such as workflow challenges and stigma, restrict access for populations that could benefit most. Targeted education is needed to equip providers across the globe with the practical knowledge and confidence to integrate LAI PrEP into prevention efforts and expand access to effective, individualized HIV care. In the third activity of this CME Outfitters Snack series, expert faculty from the United States, Europe, Africa, and Asia will discuss the latest information on LAI PrEP options for HIV, including expanding access for optimal patient selection, strategies for transitioning to an LAI and considerations for monitoring.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Mar 5, 2026
  • Last day to claim credit
    Mar 21, 2027 5 months left